Tocilizumab for Covid-19 — The Ongoing Search for Effective Therapies
Elemento
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicaciónTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Título
Tocilizumab for Covid-19 — The Ongoing Search for Effective Therapies
Materia
Descripción
Nearly 10 months after the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as the virus responsible for coronavirus disease 2019 (Covid-19), therapeutic options remain limited.
Fecha
2020-12-10
Tipo
Citación
Huang, Edmund, and Stanley C. Jordan. 2020. "Tocilizumab for Covid-19 — The Ongoing Search for Effective Therapies." New England Journal of Medicine 383 (24):2387-8.
Accesibilidad
Free online on NEJM.
Was this resource helpful?